|View printer-friendly version|
|December 06, 2010 4:02 p.m.|
|Teva to Present at the NASDAQ OMX 25th Investor Program|
|Jerusalem, Israel, December 6, 2010 - Jerusalem, December 6, 2010 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the NASDAQ OMX 25th Investor Program in London with Eyal Desheh, Chief Financial Officer, presenting on Tuesday, December 7, 2010.|
What: Teva Presentation at the NASDAQ OMX 25th Investor Program, London
Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries
When: Tuesday, December 7, 2010 at 9:00 AM (local time) / 4:00 AM ET
Where: www.tevapharm.com/financial/ or
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.